Latest News

Date Title Topic
07 Dec 2015 PD-1 Blockade Sets a New Benchmark in Previously Treated Metastatic Renal Cell Carcinoma (mRCC) Genitourinary cancers
General Assembly
03 Dec 2015 FDA Approves Elotuzumab for the Treatment of Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
02 Dec 2015 Lung Adenocarcinoma With HER2 Mutations Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
01 Dec 2015 Latest Lung Cancer E-Learning Now Online!
01 Dec 2015 NHS England and NICE Have Begun a Consultation on a New Cancer Drugs Fund Bioethics, legal and economic issues
30 Nov 2015 FDA Approves Nivolumab as a Single Agent for Previously Untreated BRAF Wild-Type Advanced Melanoma Melanoma - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
27 Nov 2015 FDA Approves Necitumumab to Treat Advanced Squamous NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Nov 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Pemetrexed Accord and Pemetrexed Actavis Lung and other thoracic tumours - Anticancer agents & Biologic therapy
25 Nov 2015 FDA Approves Ixazomib, New Oral Proteasome Inhibitor for Treatment of Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
24 Nov 2015 FDA Approves Nivolumab for the Treatment of Advanced Renal Cell Cancer Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
24 Nov 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Asparaginase and Pegaspargase Haematologic malignancies - Anticancer agents & Biologic therapy
CME Tests for Handbooks
19 Nov 2015 FDA Approves Daratumumab for Patients With Previously Treated Multiple Myeloma Haematologic malignancies